Patent · US Active

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

US8784837B2 · kind B2 · utility

5Cited by

9References

18Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Michael Buschle · Perchtoldsdorf, AT
Andre Habel · Wien, AT
Jörg Fritz · Wien, AT
Karin Prinz · Eisenlohrsweg, AT
Karen Lingnau · Wien, AT

Key dates

Filing date	Apr 13, 2010
Grant date	Jul 22, 2014
Priority date	—
Expiry date	Jun 1, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1—XZSZN—XZX—R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.